| Trial ID: | L0945 |
| Source ID: | NCT01511523
|
| Associated Drug: |
RGMA001
|
| Title: |
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of RGMA001 on Patients With Non Alcoholic Fatty Liver Disease (NAFLD).
|
| Acronym: |
--
|
| Status: |
Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non Alcoholic Fatty Liver Disease
|
| Interventions: |
Dietary Supplement: RGMA001;Dietary Supplement: Sugar Pill
|
| Outcome Measures: |
EfficacySafety
|
| Sponsor/Collaborators: |
Biovil Research Group, LLC
|
| Gender: |
All
|
| Age: |
18 Yearsnan
|
| Phases: |
Not applicable
|
| Enrollment: |
40
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Supportive Care
|
| Start Date: |
13/01/2012
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
19 February 2015
|
| Locations: |
United States
|
| URL: |
http://clinicaltrials.gov/show/NCT01511523
|
